Literature DB >> 19486644

Time-dependent alterations of peripheral immune parameters after nigrostriatal dopamine depletion in a rat model of Parkinson's disease.

Harald Engler1, Raphael Doenlen, Carsten Riether, Andrea Engler, Maj-Britt Niemi, Hugo O Besedovsky, Adriana del Rey, Gustavo Pacheco-López, Joram Feldon, Manfred Schedlowski.   

Abstract

Dysfunction of the central dopaminergic system is associated with neurodegenerative disorders and mental illnesses such as Parkinson's disease and schizophrenia. Patients suffering from these diseases were reported to exhibit altered immune functions compared to healthy subjects and imbalance of the central dopaminergic system has been suggested as one causative factor for the immune disturbances. However, it is unclear whether the observed immune changes are primary or secondary to the disease. Here we demonstrate that central dopamine (DA) depletion in a rat model of Parkinson's disease induced transient changes in blood leukocyte distribution and cytokine production that were apparent until four weeks after bilateral intrastriatal administration of the neurotoxin 6-hydroxydopamine (6-OHDA). Eight weeks after treatment, no differences in blood immune parameters were anymore evident between neurotoxin-treated and control animals. Nevertheless, animals with a widespread damage of dopaminergic neurons in the nigrostriatal system showed an exacerbated pro-inflammatory response following in vivo challenge with bacterial lipopolysaccharide. Our data indicate that peripheral immune perturbations in the early phase after intrastriatal 6-OHDA administration might have been related to the neurodegenerative process itself whereas the increased sensitivity to the inflammatory stimulus seems to have resulted from an impaired dopaminergic control of prolactin (PRL) and corticosterone (CORT) secretion. The findings demonstrate that the brain dopaminergic system is involved in peripheral immune regulation and suggest that central dopaminergic hypoactivity bears the risk of excessive inflammation, e.g., during infection or tissue injury.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19486644     DOI: 10.1016/j.bbi.2009.01.018

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  17 in total

1.  Prolactin concentrations in newly diagnosed, antipsychotic-naïve patients with nonaffective psychosis.

Authors:  Clemente Garcia-Rizo; Emilio Fernandez-Egea; Cristina Oliveira; Azucena Justicia; Eduard Parellada; Miguel Bernardo; Brian Kirkpatrick
Journal:  Schizophr Res       Date:  2011-08-09       Impact factor: 4.939

Review 2.  Neuro-Immune Mechanisms Regulating Social Behavior: Dopamine as Mediator?

Authors:  Ashley M Kopec; Caroline J Smith; Staci D Bilbo
Journal:  Trends Neurosci       Date:  2019-03-16       Impact factor: 13.837

Review 3.  Where Is Dopamine and how do Immune Cells See it?: Dopamine-Mediated Immune Cell Function in Health and Disease.

Authors:  S M Matt; P J Gaskill
Journal:  J Neuroimmune Pharmacol       Date:  2019-05-11       Impact factor: 4.147

4.  A novel approach to study markers of dopamine signaling in peripheral immune cells.

Authors:  Adithya Gopinath; Andria Doty; Phillip M Mackie; Basil Hashimi; Madison Francis; Leila Saadatpour; Kaustuv Saha; Gerry Shaw; Adolfo Ramirez-Zamora; Michael S Okun; Wolfgang J Streit; Habibeh Khoshbouei
Journal:  J Immunol Methods       Date:  2019-10-18       Impact factor: 2.303

Review 5.  α-Synuclein in Parkinson's disease: causal or bystander?

Authors:  Peter Riederer; Daniela Berg; Nicolas Casadei; Fubo Cheng; Joseph Classen; Christian Dresel; Wolfgang Jost; Rejko Krüger; Thomas Müller; Heinz Reichmann; Olaf Rieß; Alexander Storch; Sabrina Strobel; Thilo van Eimeren; Hans-Ullrich Völker; Jürgen Winkler; Konstanze F Winklhofer; Ullrich Wüllner; Friederike Zunke; Camelia-Maria Monoranu
Journal:  J Neural Transm (Vienna)       Date:  2019-06-25       Impact factor: 3.575

Review 6.  The immunoregulatory role of dopamine: an update.

Authors:  Chandrani Sarkar; Biswarup Basu; Debanjan Chakroborty; Partha Sarthi Dasgupta; Sujit Basu
Journal:  Brain Behav Immun       Date:  2009-11-05       Impact factor: 7.217

7.  PROLACTIN LEVEL IN PATIENTS WITH FIRST EPISODE SCHIZOPHRENIA TREATED FOR ONE YEAR WITH ATYPICAL ANTIPSYCHOTICS.

Authors:  V P Matei; T Purnichi; A Mihailescu; R Grigoras
Journal:  Acta Endocrinol (Buchar)       Date:  2018 Oct-Dec       Impact factor: 0.877

8.  Parkinson's disease and systemic inflammation.

Authors:  Carina C Ferrari; Rodolfo Tarelli
Journal:  Parkinsons Dis       Date:  2011-02-22

9.  Immunomodulation Mechanism of Antidepressants: Interactions between Serotonin/Norepinephrine Balance and Th1/Th2 Balance.

Authors:  Matteo Martino; Giulio Rocchi; Andrea Escelsior; Michele Fornaro
Journal:  Curr Neuropharmacol       Date:  2012-06       Impact factor: 7.363

Review 10.  Immune responses in Parkinson's disease: interplay between central and peripheral immune systems.

Authors:  Xiaomin Su; Howard J Federoff
Journal:  Biomed Res Int       Date:  2014-04-13       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.